Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen Era
Corey A. Carter(Walter Reed National Military Medical Center), Judd W. Moul(General Marble (Greece)), Douglas W. Soderdahl(Eisenhower Medical Center), Wade J. Sexton(Madigan Army Medical Center), Timothy F. Donahue(Memorial Sloan Kettering Cancer Center), Leon Sun(Madigan Army Medical Center), Stephen V. Jackman(University of Pittsburgh), Christopher L. Amling(Oregon Health & Science University), Andrew Chung(Madigan Army Medical Center), Hongyu Wu(Qingdao University), Raymond Lance(Madigan Army Medical Center), David G. McLeod(George Washington University), John Foley(Princeton University), Leo Kusuda(Madigan Army Medical Center)
Cited by 81
Related Papers
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy
|The Journal of Urology|2003|293